Form 4 Tracker
Hims & Hers Health, Inc.
HIMS

92 insider filings · Latest: Oct 14, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Aug 19, 2026Aug 20 8:30 PMSoleil BoughtonChief Legal Officer
Sale
25,111$27.55$691.8K313,964(D)

View →

Aug 19, 2026Aug 19 1:41 PMBoughton Soleil
Proposed Sale
25,111$27.55$691.8K—

View →

Aug 17, 2026Aug 18 9:04 PMOluyemi OkupeChief Financial Officer
Sale
9,388$27.89$261.8K264,117(D)

View →

Jun 18, 2026Aug 18 9:04 PMOluyemi OkupeChief Financial Officer
Sale
55,383$35.09$1.9M228,938(D)

View →

Aug 18, 2026Aug 18 2:37 PMAutor Deborah M.
Proposed Sale
16,773$27.85$467.1K—

View →

Jul 22, 2026Jul 22 3:12 PMPendarvis Christiane
Proposed Sale
3,500$32.37$113.3K—

View →

Jul 17, 2026Jul 20 8:30 PMOluyemi OkupeChief Financial Officer
Sale
7,163$31.99$229.2K284,321(D)

View →

Jul 6, 2026Jul 7 8:20 PMOluyemi OkupeChief Financial Officer
Sale
7,163$36.49$261.4K284,321(D)

View →

Jul 6, 2026Jul 6 10:17 PMOluyemi Okupe
Proposed Sale
28,652$38.28$1.1M—

View →

Jun 18, 2026Jun 23 10:39 PMPatrick Harrison CarrollChief Medical Officer
Sale
23,726$35.00$830.4K181,861(D)

View →

Jun 22, 2026Jun 23 10:39 PMOluyemi OkupeChief Financial Officer
Sale
18,197$34.03$619.2K284,321(D)

View →

Jun 18, 2026Jun 18 7:02 PMCarroll Patrick Harrison
Proposed Sale
23,726$35.00$830.4K—

View →

Jun 17, 2026Jun 17 10:50 PMMichael ChiChief Operating Officer
Sale
14,027$31.50$441.9K432,124(D)

View →

Jun 17, 2026Jun 17 10:50 PMIrene BecklundPAO
Sale
4,490$31.50$141.4K6,790(D)

View →

Jun 16, 2026Jun 17 10:50 PMIrene BecklundPAO
Sale
7,573$30.25$229.1K11,280(D)

View →

Jun 17, 2026Jun 17 10:50 PMMohamed ElshenawyCTO
Sale
30,040$31.50$946.3K101,023(D)

View →

Jun 17, 2026Jun 17 3:17 PMBecklund Irene
Proposed Sale
4,490$31.50$141.4K—

View →

Jun 17, 2026Jun 17 3:10 PMElshenawy Mohamed
Proposed Sale
30,040$31.50$946.3K—

View →

Jun 17, 2026Jun 17 1:47 PMChi Michael
Proposed Sale
14,027$31.50$441.9K—

View →

Jun 16, 2026Jun 16 3:21 PMBecklund Irene
Proposed Sale
7,573$30.25$229.1K—

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 11, 2026Jun 15 9:13 PMPatrick Harrison CarrollChief Medical Officer
Option Exercise
3,656—0(D)

View →

Jun 11, 2026Jun 15 9:13 PMDeborah M. AutorDirector, Chief Policy Officer
Option Exercise
3,656—0(D)

View →

Jun 15, 2026Jun 15 9:13 PMChristopher D PayneDirector
Option Exercise
10,687—0(D)

View →

Jun 11, 2026Jun 15 9:13 PMChristopher D PayneDirector
Option Exercise
3,656—0(D)

View →

Jun 11, 2026Jun 15 9:12 PMChristiane PendarvisDirector
Option Exercise
3,656—0(D)

View →

Jun 15, 2026Jun 15 9:12 PMAnja ManuelDirector
Option Exercise
10,040—10,040(D)

View →

Jun 11, 2026Jun 15 9:12 PMAnja ManuelDirector
Option Exercise
3,656—0(D)

View →

Jun 11, 2026Jun 15 9:12 PMDelos M. CosgroveDirector
Option Exercise
3,656—0(D)

View →

May 20, 2026May 22 8:16 PMPatrick Harrison CarrollDirector, Chief Medical Officer
Grant/Award
435—435(D)

View →

May 20, 2026May 22 8:16 PMChristopher D PayneDirector
Grant/Award
647—647(D)

View →

May 20, 2026May 22 8:16 PMDavid B WellsDirector
Grant/Award
957—957(D)

View →

May 18, 2026May 19 11:39 PMOluyemi OkupeChief Financial Officer
Option Exercise
7,950$5.01115,900(D)

View →

Apr 20, 2026Apr 22 9:24 PMOluyemi OkupeChief Financial Officer
Option Exercise
12,553$11.5335,996(D)

View →

Apr 17, 2026Apr 20 8:38 PMOluyemi OkupeChief Financial Officer
Option Exercise
6,184$5.01129,403(D)

View →

Apr 6, 2026Apr 7 9:14 PMOluyemi OkupeChief Financial Officer
Option Exercise
3,975$5.01135,587(D)

View →

Mar 20, 2026Mar 24 10:09 PMOluyemi OkupeChief Financial Officer
Option Exercise
4,489$5.01139,562(D)

View →

Mar 13, 2026Mar 17 8:29 PMMichael ChiChief Operating Officer
Option Exercise
72,108—127,191(D)

View →

Mar 13, 2026Mar 17 8:29 PMChristiane PendarvisDirector
Option Exercise
15,211—0(D)

View →

Mar 13, 2026Mar 17 8:29 PMPatrick Harrison CarrollDirector, Chief Medical Officer
Option Exercise
16,522—42,397(D)

View →

Mar 13, 2026Mar 17 8:29 PMDeborah M. AutorDirector, Chief Policy Officer
Option Exercise
32,919—493,792(D)

View →